Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine

Keyphrases

• Signal Peptide 100%
• Adenoviral 100%
• Immunogenicity 100%
• Plasmodium Vivax 100%
• Multistage Vaccine 100%
• Malaria Vaccine 37%
• T Cells 25%
• CD8+ 25%
• Vaccine Candidate 25%
• Vaccine Platform 25%
• Pre-erythrocytic Stages 25%
• Viral Vector Vaccine 25%
• Recombinant 12%
• CD4+ 12%
• CD4+ T Cells 12%
• Interleukin-2 12%
• Cytokine Production 12%
• Immunization 12%
• Recombinant Protein 12%
• Humoral Immune Response 12%
• Clinical Assessment 12%
• Vector Encoding 12%
• Adenovirus Vector 12%
• Plasmodium Infection 12%
• Proof of Concept Study 12%
• Plasmodium 12%
• DNA Vaccine 12%
• Light Chain 12%
• Cellular Immune Response 12%
• Recombinant Adenovirus 12%
• CD4+ T Cell Response 12%
• Peptide Signaling 12%
• Montanide 12%
• Simian Adenovirus 12%
• Protein-based Vaccine 12%
• Antibody Avidity 12%
• Adenovirus 36 12%
• Quality Production 12%
• Immunization Regimen 12%

Immunology and Microbiology

• Vaccine Efficacy 100%
• Murine 100%
• Immunogenicity 100%
• Plasmodium vivax 100%
• Mouse 37%
• CD8 25%
• T Cell 25%
• T-Helper Cell 25%
• Plasmodium 25%
• Adenovirus Vector 25%
• Viral Vector 25%
• RTS,S 25%
• Monospecific Antibody 12%
• Transgene 12%
• CD4 12%
• Adoptive Immunity 12%
• Humoral Immunity 12%
• Cytokine Production 12%
• Light Chain 12%
• DNA Vaccine 12%
• Montanide ISA 51 12%
• Simian Virus 12%
• CB6F1 Mouse 12%